Labman Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 17.30%
- Profit Growth -102.48%
- Ebitda -24.69%
- Net Worth -1.04%
- Total Assets 26.15%
About Labman Diagnostic
Labman Diagnostic Private Limited (LDPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 02 April 2019 (Five years and ten months 1 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bharatkumar Menat, Pritiben Solanki, Pareshkumar Govinda, and One other member serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2019PTC107414
-
Company No.
107414
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Apr 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Labman Diagnostic?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharatkumar Menat
|
Director | 02-Apr-2019 | Current |
|
Pritiben Solanki
|
Director | 02-Apr-2019 | Current |
|
Pareshkumar Govinda
|
Director | 04-Feb-2022 | Current |
|
Bindra Patel
|
Director | 04-Feb-2022 | Current |
Financial Performance of Labman Diagnostic.
Labman Diagnostic Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.3% increase. The company also saw a substantial fall in profitability, with a 102.48% decrease in profit. The company's net worth dipped by a decrease of 1.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Labman Diagnostic?
Unlock access to Labman Diagnostic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Labman Diagnostic?
Unlock and access historical data on people associated with Labman Diagnostic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Labman Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Labman Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.